0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nootropics - Global Strategic Business Report

  • PDF Icon

    Report

  • 269 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6070710
Description Jump to:
The global market for Nootropics was estimated at US$4.8 Billion in 2024 and is projected to reach US$11.3 Billion by 2030, growing at a CAGR of 15.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Nootropics market.

Global Nootropics Market - Key Trends & Drivers Summarized

Why Are Nootropics Gaining Ground as a Mainstream Wellness Essential in a Cognitive-Driven World?

The global rise of nootropics - cognitive-enhancing substances used to improve memory, focus, creativity, and mental clarity - signals a dramatic shift in how individuals prioritize brain health in their overall wellness routines. Once confined to niche communities of students, gamers, and tech professionals, nootropics have now entered the mainstream as consumers across demographics seek solutions to combat mental fatigue, cognitive overload, and stress-related impairments. This growing demand is fueled by the proliferation of high-pressure work environments, hybrid and remote work setups, digital overstimulation, and lifestyle-induced burnout. Whether it's a busy executive looking for mental clarity, a student preparing for exams, or a retiree seeking to maintain cognitive vitality, nootropics are being embraced as proactive, non-prescription tools to enhance brain performance. The pandemic further accelerated this shift, highlighting mental resilience as a health priority. Unlike pharmaceuticals, most nootropics are available as supplements or functional foods, making them easily accessible through online and retail channels without a clinical gatekeeper. Popular ingredients include L-theanine, caffeine, Lion's Mane mushroom, Bacopa monnieri, Rhodiola rosea, and Alpha-GPC - formulated either as standalone products or in synergistic blends. The conversation around brain optimization is now extending beyond temporary cognitive boosts to long-term mental longevity, with consumers increasingly viewing nootropics as integral to daily self-care. As cognitive performance becomes a key marker of modern productivity and wellness, the cultural shift toward brain-focused supplementation is expected to deepen and diversify.

How Are Innovation and Personalization Redefining the Future of Nootropic Product Development?

Rapid innovation in formulation, delivery formats, and personalized solutions is reshaping the nootropics market, elevating its credibility, appeal, and functionality. Today's consumers demand more than generic brain boosters - they want targeted, transparent, and scientifically supported products that align with their cognitive goals and lifestyle needs. Brands are responding by offering tailored nootropic stacks designed for specific use-cases such as deep work, creative ideation, stress reduction, memory recall, and mood enhancement. New-generation nootropics combine well-studied natural ingredients with emerging compounds like Noopept, Citicoline, and phosphatidylserine to provide more potent and longer-lasting effects. The rise of biotech and neuroscience-driven R&D has enabled deeper insights into how these compounds interact with neurotransmitters, enabling manufacturers to design products with enhanced bioavailability and multi-pathway efficacy. Delivery systems have also evolved, with options now ranging from capsules, gummies, and powders to energy shots, cognitive beverages, and even transdermal patches. Clean-label trends have prompted formulators to steer clear of synthetic fillers, allergens, and GMOs, instead emphasizing organic, vegan, and adaptogen-based compositions. Beyond ingredients, technology is driving hyper-personalization, with companies leveraging apps, genetic testing, and lifestyle questionnaires to offer customized nootropic solutions based on individual brain chemistry and behavior patterns. Subscription-based services and D2C models are also playing a major role in creating an ongoing consumer-brand relationship. With heightened focus on both efficacy and experience, innovation is not only fueling product differentiation but also helping the nootropics category evolve from generic supplements into personalized brain health ecosystems.

How Are Lifestyle Shifts, Mental Wellness Movements, and Demographics Driving Market Expansion?

The rapid expansion of the nootropics market is rooted in sweeping societal and lifestyle shifts that are redefining health, aging, and performance. As cognitive function becomes a vital currency in the knowledge economy, individuals are increasingly investing in products that help them think sharper, adapt faster, and manage stress better. This shift is particularly visible among millennials and Gen Z, who actively seek out nootropics as part of a holistic approach to wellness that includes mental clarity, emotional resilience, and neuroprotection. The aging global population is also contributing to rising demand, as older adults look for natural, non-prescription solutions to manage age-related cognitive decline and preserve mental sharpness. At the same time, the surge in mental health awareness has brought brain function into focus not just as a medical concern, but as a proactive lifestyle objective. From mindfulness apps and journaling to stress-reducing supplements, cognitive wellness has become a key pillar of self-care culture. Influencer marketing, health podcasts, wellness communities, and digital platforms have made it easier for brands to educate and engage consumers in this category. Moreover, the rise of work-from-anywhere lifestyles, screen fatigue, and digital multitasking is reinforcing the need for products that support mental stamina and focus throughout the day. In academic settings, athletes, and competitive professions, cognitive edge is increasingly considered an advantage, normalizing the use of brain-supporting supplements. This cultural recalibration is expanding the target audience for nootropics far beyond the early adopters, helping the market transition from fringe to mainstream.

What's Fueling the Growth of the Global Nootropics Market?

The growth in the nootropics market is driven by several factors including technological advancements, evolving consumer behavior, changing healthcare priorities, and expanding distribution ecosystems. First, improvements in neuroscience, clinical research, and nutraceutical formulation science are enabling the development of evidence-based, bioavailable nootropics with proven cognitive effects, which is boosting consumer confidence and credibility of the category. Second, there is rising demand from diverse consumer segments - from young professionals and students to older adults and biohackers - all seeking improved mental performance, focus, and long-term cognitive protection. Third, the shift toward preventative and performance-oriented wellness is driving demand for functional supplements that support brain health without relying on prescription drugs. Fourth, the market is benefiting from the proliferation of e-commerce platforms, D2C startups, and global wellness retailers, which are expanding product accessibility and brand reach. Fifth, increased investments by venture capital firms and supplement manufacturers are driving product innovation and accelerating time-to-market for new formulations. Regulatory openness in key markets, combined with clearer guidelines for functional food labeling and supplement claims, is also improving market entry pathways for both new and existing players. Consumer demand for clean-label, vegan, and sustainable products is further driving differentiation and premiumization within the space. Finally, the convergence of nootropics with wearable tech, personalized wellness apps, and cognitive tracking platforms is creating a comprehensive brain optimization ecosystem, positioning nootropics as central to the future of cognitive and mental wellness. Together, these drivers are fueling sustained and dynamic growth in the global nootropics market.

Scope of Study:

The report analyzes the Nootropics market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Form (Capsules / Tablets Form, Powder Form, Drinks Form, Other Forms); Distribution Channel (Offline Distribution Channels, Online Distribution Channels)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Capsules / Tablets Form segment, which is expected to reach US$6.2 Billion by 2030 with a CAGR of a 16.4%. The Powder Form segment is also set to grow at 16.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $1.3 Billion in 2024, and China, forecasted to grow at an impressive 20.5% CAGR to reach $2.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nootropics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nootropics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nootropics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as BrainMD Health, Bulletproof 360, Inc., Cymbiotika LLC, Designs for Health, Douglas Laboratories and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 32 companies featured in this Nootropics market report include:

  • BrainMD Health
  • Bulletproof 360, Inc.
  • Cymbiotika LLC
  • Designs for Health
  • Douglas Laboratories
  • Elysium Health Inc.
  • HVMN Inc.
  • Jarrow Formulas, Inc.
  • Life Extension
  • Mind Lab Pro (Opti-Nutra Ltd.)
  • Natural Stacks
  • Neurohacker Collective
  • NeuroScience, Inc.
  • Nootrobox (H.V.M.N.)
  • Nootropics Depot
  • NOW Foods
  • Onnit Labs, Inc.
  • Pure Nootropics, LLC
  • Qualia (Neurohacker Collective)
  • Thorne HealthTech, Inc.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Nootropics - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Cognitive Health Awareness Throws the Spotlight on Nootropics as a Core Wellness Category
Digital Lifestyle Stressors and Mental Fatigue Spur Growth in Focus and Energy-Enhancing Nootropic Products
Neuroscience-Driven Innovation Strengthens the Business Case for Evidence-Based Nootropic Formulations
Adoption of Plant-Based and Clean-Label Cognitive Enhancers Expands the Addressable Market Opportunity
Gamification of Productivity and Biohacking Culture Accelerates Demand Among Younger, Performance-Focused Consumers
Here`s How Aging Populations Are Driving Demand for Memory-Enhancing and Neuroprotective Nootropic Solutions
Evolving Role of Personalized Nutrition Generates Opportunities for Customized Nootropic Stacks
Direct-to-Consumer Platforms and Subscriptions Drive Adoption of Nootropics in Everyday Routines
Functional Foods and Beverages Infused with Cognitive Ingredients Expand Market Reach Beyond Traditional Supplements
Cross-Category Convergence with Mood, Sleep, and Stress Products Strengthens Positioning of Nootropic Offerings
Advances in Delivery Formats, From Gummies to Liquid Shots, Drive Convenience-Oriented Consumption
Integration of Wearables and Cognitive Monitoring Tools Enhances Efficacy Claims and Drives Usage
Here`s the Story: Preventive Brain Health Trends Sustain Long-Term Growth Momentum in the Global Nootropics Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Nootropics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Nootropics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Nootropics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Nootropics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Capsules / Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Capsules / Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Drinks Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Drinks Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Drinks Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Offline Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Offline Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Offline Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Online Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Online Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Online Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: USA 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: USA Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: USA 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: Canada 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: Canada 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
JAPAN
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: Japan 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: Japan 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
CHINA
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: China 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: China Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: China 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
EUROPE
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Nootropics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Nootropics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Europe 15-Year Perspective for Nootropics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Europe 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Europe 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
FRANCE
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: France 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: France Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: France 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
GERMANY
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Germany 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Germany 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: Italy 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: Italy 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
UNITED KINGDOM
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: UK 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: UK Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: UK 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Spain 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Spain 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Russia 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Russia 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Rest of Europe 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Nootropics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Nootropics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Nootropics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Nootropics by Form - Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Asia-Pacific 15-Year Perspective for Nootropics by Form - Percentage Breakdown of Value Sales for Capsules / Tablets Form, Powder Form, Drinks Form and Other Forms for the Years 2015, 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Nootropics by Distribution Channel - Offline Distribution Channels and Online Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Asia-Pacific 15-Year Perspective for Nootropics by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channels and Online Distribution Channels for the Years 2015, 2025 & 2030
AUSTRALIA
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Nootropics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BrainMD Health
  • Bulletproof 360, Inc.
  • Cymbiotika LLC
  • Designs for Health
  • Douglas Laboratories
  • Elysium Health Inc.
  • HVMN Inc.
  • Jarrow Formulas, Inc.
  • Life Extension
  • Mind Lab Pro (Opti-Nutra Ltd.)
  • Natural Stacks
  • Neurohacker Collective
  • NeuroScience, Inc.
  • Nootrobox (H.V.M.N.)
  • Nootropics Depot
  • NOW Foods
  • Onnit Labs, Inc.
  • Pure Nootropics, LLC
  • Qualia (Neurohacker Collective)
  • Thorne HealthTech, Inc.

Table Information

Report AttributeDetails
No. of Pages269
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.3 Billion
Compound Annual Growth Rate15.4%
Regions CoveredGlobal

Related Topics

Related Reports

Nootropics Market by Form, Distribution Channel, Function, End User, Nature - Global Forecast to 2030 - Product Image

Nootropics Market by Form, Distribution Channel, Function, End User, Nature - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Nootropics Market Report 2025 - Product Image

Nootropics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Nootropic Supplements - Global Strategic Business Report - Product Image

Nootropic Supplements - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
EUR$5,850USDGBP
Nootropics Market Report and Forecast 2024-2032 - Product Image

Nootropics Market Report and Forecast 2024-2032

  • Report
  • 150 Pages
  • Global
From
EUR$4,949USDGBP
Nootropic Brain Supplement Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Nootropic Brain Supplement Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
EUR$3,250USDGBP
EUR$4,850USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more